圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688289 圣湘生物

交易中 03-11 14:21:12

{"stockData":{"symbol":"688289","market":"SH","secType":"STK","nameCN":"圣湘生物","latestPrice":25.84,"timestamp":1741674072000,"preClose":25.72,"halted":0,"volume":7894728,"delay":0,"changeRate":0.0047,"floatShares":579000000,"shares":579000000,"eps":0.4478,"marketStatus":"交易中","change":0.12,"latestTime":"03-11 14:21:12","open":25.38,"high":25.9,"low":25.32,"amount":203000000,"amplitude":0.0226,"askPrice":25.84,"askSize":94,"bidPrice":25.81,"bidSize":35,"shortable":0,"etf":0,"ttmEps":0.4478,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1741676400000},"marketStatusCode":2,"adr":0,"adjPreClose":25.72,"symbolType":"stock_kcb","openAndCloseTimeList":[[1741656600000,1741663800000],[1741669200000,1741676400000]],"highLimit":28.29,"lowLimit":23.15,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":579388006,"isCdr":false,"pbRate":2.06,"roa":"--","peRate":57.704332,"roe":"2.69%","epsLYR":0.62,"committee":-0.92517,"marketValue":14971000000,"turnoverRate":0.0136,"status":0,"floatMarketCap":14971000000},"requestUrl":"/m/hq/s/688289","defaultTab":"news","newsList":[{"id":"2518246562","title":"圣湘生物03月10日获主力加仓4480万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518246562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518246562?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:19","pubTimestamp":1741591191,"startTime":"0","endTime":"0","summary":"03月10日, 圣湘生物股价涨1.94%，报收25.72元，成交金额4.26亿元，换手率2.84%，振幅3.77%，量比0.86。圣湘生物今日主力资金净流入4480万元，连续3日净流入，上一交易日主力净流入7057万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为57.14%，平均涨幅为1.14%。该股近5个交易日上涨20.58%，主力资金累计净流入1.12亿元；近20日主力资金累计净流出8711万元，其中净流出天数为14日。该行业中净流入前三个股分别为迈瑞医疗、圣湘生物、艾德生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310155434abf272dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310155434abf272dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688289","BK0239"],"gpt_icon":0},{"id":"2518257148","title":"估值41.5亿元！真迈生物再获圣湘生物1.3亿元新投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2518257148","media":"猎云网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518257148?lang=zh_cn&edition=full","pubTime":"2025-03-10 09:32","pubTimestamp":1741570324,"startTime":"0","endTime":"0","summary":"来源：猎云网近日，圣湘生物发布公告称，拟与关联方湖南湘江圣湘生物产业基金合伙企业共同投资深圳市真迈生物科技有限公司，其中，公司以自有资金合计投资1.3亿元，通过受让股权及增资交易后，公司对真迈生物的持股比例将由11.903047%增加至15.549381%。据悉，本次交易真迈生物老股金额8666万元+新股增资金额19333万元，合计2.8亿元，估值达到41.5亿元。交易完成后，圣湘生物持有真迈生物的股权由12.91%降至11.90%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031009321198a1e7dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031009321198a1e7dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688289","BK0239"],"gpt_icon":0},{"id":"2517452538","title":"每周股票复盘：圣湘生物（688289）因收盘价格涨幅达15%首登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2517452538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517452538?lang=zh_cn&edition=full","pubTime":"2025-03-08 03:04","pubTimestamp":1741374252,"startTime":"0","endTime":"0","summary":"截至2025年3月7日收盘，圣湘生物报收于25.23元，较上周的21.35元上涨18.17%。本周，圣湘生物3月7日盘中最高价报26.09元，股价触及近一年最高点。圣湘生物当前最新总市值146.18亿元，在医疗器械板块市值排名17/124，在两市A股市值排名1121/5130。本周关注点交易信息汇总：圣湘生物因收盘价格涨幅达到15%首次登上龙虎榜交易信息汇总沪深交易所2025年3月4日公布的交易公开信息显示，圣湘生物因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030800054372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"gpt_icon":0},{"id":"2517878734","title":"圣湘生物(688289.SH)拟1.3亿元投资真迈生物 完善基因测序领域产业链布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2517878734","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517878734?lang=zh_cn&edition=full","pubTime":"2025-03-07 20:50","pubTimestamp":1741351821,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣湘生物 发布公告，公司拟与关联方湖南湘江圣湘生物产业基金合伙企业共同投资深圳市真迈生物科技有限公司，其中，公司以自有资金合计投资1.3亿元，通过受让股权及增资交易后，公司对真迈生物的持股比例将由11.903047%增加至15.549381%。真迈生物专注于基因测序产业上游设备和试剂的研发制造，拥有包括荧光检测、核酸修饰、染料合成、酶突变、表面化学工艺等“卡脖子”技术的自研自产能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688289","BK0239"],"gpt_icon":0},{"id":"2517878404","title":"圣湘生物：拟与关联方产业基金共同投资真迈生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2517878404","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517878404?lang=zh_cn&edition=full","pubTime":"2025-03-07 20:29","pubTimestamp":1741350591,"startTime":"0","endTime":"0","summary":"格隆汇3月7日丨圣湘生物公布，为进一步落实公司战略规划，完善公司在基因测序领域的产业链布局，保持综合竞争力，公司于2025年3月7日召开第二届董事会2025年第四次临时会议，审议通过了《圣湘生物科技股份有限公司关于受让参股公司部分股权并增资暨与关联方共同投资的议案》。同意公司与关联方产业基金共同投资真迈生物。其中，公司以自有资金合计投资1.3亿元，通过受让股权及增资交易后，公司对真迈生物的持股比例将由11.903047%增加至15.549381%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307203328989fd7a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307203328989fd7a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688289"],"gpt_icon":0},{"id":"2517108105","title":"圣湘生物03月07日获主力加仓7057万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517108105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517108105?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:21","pubTimestamp":1741332067,"startTime":"0","endTime":"0","summary":"03月07日, 圣湘生物股价涨1.04%，报收25.23元，成交金额5.19亿元，换手率3.51%，振幅5.69%，量比1.24。圣湘生物今日主力资金净流入7057万元，上一交易日主力净流入4077万元。|03月07日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|金帝股份|5.99%|#|利欧股份|5.80%|#|铭科精技|5.66%|#|恒勃股份|5.36%|#|天舟文化|5.30%|#|联合精密|5.20%|#|神剑股份|4.89%|#|方正电机|4.62%|#|云赛智联|4.27%|#|川大智胜|4.04%|圣湘生物所在的医疗器械行业，今日主力净流出4.15亿元，行业排名34/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307161641abecafa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307161641abecafa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688289","BK0239"],"gpt_icon":0},{"id":"2517969226","title":"圣湘生物董事长：加快融合人工智能等新兴技术，以数智化赋能医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2517969226","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517969226?lang=zh_cn&edition=full","pubTime":"2025-03-05 15:39","pubTimestamp":1741160370,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","688289","161631","159891"],"gpt_icon":0},{"id":"2517960760","title":"圣湘生物03月05日主力净流出4695万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517960760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517960760?lang=zh_cn&edition=full","pubTime":"2025-03-05 15:21","pubTimestamp":1741159300,"startTime":"0","endTime":"0","summary":"03月05日, 圣湘生物股价跌1.83%，报收24.13元，成交金额4.79亿元，换手率3.42%，振幅4.84%，量比1.77。圣湘生物今日主力资金净流出4695万元，上一交易日主力净流入282万元。该股近5个交易日上涨8.69%，主力资金累计净流出8649万元；近20日主力资金累计净流出2.46亿元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305162801abe934f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305162801abe934f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688289"],"gpt_icon":0},{"id":"2516629623","title":"3月4日圣湘生物（688289）龙虎榜数据：游资上海超短帮上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2516629623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516629623?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:29","pubTimestamp":1741080541,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年3月4日公布的交易公开信息显示，圣湘生物因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年3月4日收盘，圣湘生物报收于24.58元，上涨15.24%，换手率5.32%，成交量30.81万手，成交额7.19亿元。上海超短帮等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030400030135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"gpt_icon":0},{"id":"2516614731","title":"圣湘生物上涨6.75%，报22.77元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516614731","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516614731?lang=zh_cn&edition=full","pubTime":"2025-03-04 13:41","pubTimestamp":1741066869,"startTime":"0","endTime":"0","summary":"3月4日，圣湘生物盘中上涨6.75%，截至13:41，报22.77元/股，成交1.66亿元，换手率1.33%，总市值131.93亿元。截至9月30日，圣湘生物股东户数1.98万，人均流通股2.94万股。2024年1月-9月，圣湘生物实现营业收入10.33亿元，同比增长63.24%；归属净利润1.95亿元，同比减少34.80%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/04134148505024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688289","BK0239"],"gpt_icon":0},{"id":"2516961410","title":"圣湘生物涨5% 近半年6家券商买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2516961410","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516961410?lang=zh_cn&edition=full","pubTime":"2025-03-04 13:40","pubTimestamp":1741066809,"startTime":"0","endTime":"0","summary":"03月04日，圣湘生物股价大幅上涨，截至13点40分，圣湘生物上涨5.06%，报22.41元/股，成交1.52亿元，换手率1.21%，振幅6.24%。此外，数据统计显示，近半年内6家券商给予买入建议。资金动向截止发稿，圣湘生物获得主力净流出1200万元，其中超大单流出888万元，大单流出310万元。最新财报显示，今年三季报，圣湘生物实现营业收入10.33亿元，同比增长63.24%，净利润为1.95亿元，同比减少34.80%，基本每股收益为0.34元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304134042a25e4d49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304134042a25e4d49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688289","BK0239"],"gpt_icon":0},{"id":"2516942276","title":"中国脑机接口行业发展与展望：医疗器械专题之脑机接口","url":"https://stock-news.laohu8.com/highlight/detail?id=2516942276","media":"华安证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516942276?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:00","pubTimestamp":1741017600,"startTime":"0","endTime":"0","summary":"政策引导+技术突破，全球脑机接口产业进入高速发展阶段，中国非侵入式脑机接口技术全球领先。中国围绕非侵入式脑机接口方向，实现弯道超车，首创实现“双环路”脑机交互系统，打破了传统脑机接口的信息交互，并极大突破了操控时间的限制，该技术突破使得中国在非侵入式脑机接口领域处于全球领先地位。医疗健康是当前脑机接口最成熟的赛道，覆盖神经疾病诊断、康复治疗及功能替代。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688358","688050","600807","688338","688575","688317","688576","688393","688767","688298","688606","688217","688114","605369","688212","603205","688613","688468","688253","688351","688277","688617","688198","688085","688273","688410","BK0251","688067","688161","688426","688607","688026","600529","688289","688580","688139","688366","603976","688068","603309","603387","603880","688151","688677","BK0114","688013","600587","688271","603987","603658","603301","603222","688075","688029","688108","688236","688301","688389","688656","BK0070","BK0146","688399","688626","688193","688314","688581","159883","600645","688016","600055"],"gpt_icon":0},{"id":"2516582400","title":"每周股票复盘：圣湘生物（688289）2024年净利润2.59亿元，同比下降28.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516582400","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516582400?lang=zh_cn&edition=full","pubTime":"2025-03-01 10:42","pubTimestamp":1740796929,"startTime":"0","endTime":"0","summary":"截至2025年2月28日收盘，圣湘生物报收于21.35元，较上周的23.1元下跌7.58%。本周，圣湘生物2月24日盘中最高价报23.2元。本周关注点业绩披露要点：圣湘生物2024年净利润2.59亿元，同比下降28.78%公司公告汇总：圣湘生物拟投资7,560万元，持有红岸基元54%股权业绩披露要点圣湘生物近日即将发布2024年年报，根据2月27日发布的业绩快报，归属净利润盈利2.59亿元，同比减少28.78%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030100012638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289"],"gpt_icon":0},{"id":"2514361956","title":"呼吸道产品营收翻倍！圣湘生物去年营收大涨近5成，开年2次发起并购","url":"https://stock-news.laohu8.com/highlight/detail?id=2514361956","media":"时代周报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514361956?lang=zh_cn&edition=full","pubTime":"2025-02-28 10:06","pubTimestamp":1740708406,"startTime":"0","endTime":"0","summary":"圣湘生物于2020年8月登陆科创板。目前，呼吸道检测是圣湘生物业绩增长最快的业务板块。圣湘生物表示，公司2024年度实现营业收入14.97亿元，较上一年度同比增长48.60%。如果2024年呼吸道类产品营业收入较2023年实现翻倍，也就是说呼吸道产品营收有望超过8亿元，其占总收入的比重不低于53.44%。2025年开年，圣湘生物连续发起两起并购，其中最为热议的便是公司跨界生长激素赛道。此外，1月25日晚间，圣湘生物又披露一则收购公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281007209633486a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281007209633486a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688289"],"gpt_icon":0},{"id":"2514357908","title":"公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2514357908","media":"信达证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514357908?lang=zh_cn&edition=full","pubTime":"2025-02-28 08:06","pubTimestamp":1740701178,"startTime":"0","endTime":"0","summary":"鱼跃医疗本期内容提要:核心观点：我们认为在人口老龄化的背景下，居民健康管理及家庭康养需求提升，家用医疗器械产品市场规模有望逐步扩大。公司作为国内领先的家用医疗器械厂商，随着产品管线逐步丰富，品牌影响力不断增强，市场份额有望不断提升，业务有望保持稳健增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688139","688317","688271","688085","688298","688576","688468","688108","688161","688198","688273","688410","600807","688013","BK0070","688314","688253","688050","688607","688677","BK0146","600055","688236","688581","603222","688366","603387","688067","159883","688426","603987","688068","603880","688075","600645","605369","603658","688389","688393","688151","688617","688626","688114","600529","688289","688301","688767","BK0114","688351","688606","688029","603976","603309","688575","BK0251","688193","688580","603301","688212","688338","688358","688399","688277","688217","688656","603205","600587","688613"],"gpt_icon":0},{"id":"2514386562","title":"圣湘生物(688289.SH)：2024年度净利润2.59亿元 同比减少28.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386562","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386562?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:54","pubTimestamp":1740668067,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣湘生物(688289.SH)发布2024年度业绩快报，报告期内公司实现营业收入14.97亿元，同比增长48.60%;归属于母公司所有者的净利润2.59亿元，同比减少28.78%;归属于母公司所有者的扣除非经常性损益的净利润2.11亿元，同比增长194.13%;基本每股收益0.44元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688289"],"gpt_icon":0},{"id":"2514877385","title":"AI赋能诊疗一体化，圣湘生物营收增五成","url":"https://stock-news.laohu8.com/highlight/detail?id=2514877385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514877385?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:39","pubTimestamp":1740667157,"startTime":"0","endTime":"0","summary":"聚焦呼吸道精准诊断新蓝海，以AI赋能诊疗一体化新生态，圣湘生物正全力拥抱生命科技“奇点”时刻。2月27日晚，圣湘生物披露2024年度业绩快报。2023年，圣湘生物呼吸道类产品收入超4亿元，同比增长680%。同时，圣湘生物还以数智化赋能呼吸道医疗，创新成效显著。目前，圣湘生物的诊疗一体化布局主要涉及体外诊断、生物制造两大领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025022700041435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289"],"gpt_icon":0},{"id":"2514645874","title":"圣湘生物发布2024年度业绩快报，盈利2.59亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514645874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514645874?lang=zh_cn&edition=full","pubTime":"2025-02-27 18:31","pubTimestamp":1740652260,"startTime":"0","endTime":"0","summary":"证券之星消息，圣湘生物近日即将发布2024年年报，根据2月27日发布的业绩快报，归属净利润盈利2.59亿元，同比减少28.78%。业绩快报公告中对经营业绩和财务状况情况的说明：（一）报告期内的经营情况、财务状况及影响经营业绩的主要因素在经营业绩方面，公司 2024 年度实现营业收入 14.97 亿元，较上一年度同比增长48.60%。其中，呼吸道类产品营业收入较去年实现翻倍，成为公司业绩增长的重要引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022700033864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"gpt_icon":0},{"id":"2514874662","title":"圣湘生物最新公告：2024年净利润2.59亿元 同比下降28.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514874662","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514874662?lang=zh_cn&edition=full","pubTime":"2025-02-27 18:30","pubTimestamp":1740652233,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称，2024年度实现营业收入14.97亿元，同比增长48.60%。归属于母公司所有者的净利润2.59亿元，同比下降28.78%。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022700033845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289"],"gpt_icon":0},{"id":"2514983612","title":"开年收购两连击，圣湘生物又入局血球仪市场，打通基层检验“最后一公里”丨并购一线","url":"https://stock-news.laohu8.com/highlight/detail?id=2514983612","media":"钛媒体","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514983612?lang=zh_cn&edition=full","pubTime":"2025-02-26 19:34","pubTimestamp":1740569640,"startTime":"0","endTime":"0","summary":"图源自圣湘生物公告交易完成后，红岸基元将纳入上市公司合并报表范围内。另外，本次交易是圣湘生物进入2025年后的第二笔收购。血球仪POCT是POCT市场的细分领域之一。值得注意的是，本次收购是圣湘生物在已有业务范围对细分赛道的新押注，而这已是圣湘生物进入2025年以来宣布的第二起并购。2021年至今，圣湘生物已有8起投资并购交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261934579631267d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261934579631267d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688289"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1741674084689,"stockEarnings":[{"period":"1week","weight":0.2058},{"period":"1month","weight":0.2047},{"period":"3month","weight":0.1001},{"period":"6month","weight":0.5193},{"period":"1year","weight":0.3181},{"period":"ytd","weight":0.133}],"compareEarnings":[{"period":"1week","weight":0.0148},{"period":"1month","weight":0.0189},{"period":"3month","weight":-0.0165},{"period":"6month","weight":0.2367},{"period":"1year","weight":0.1051},{"period":"ytd","weight":0.0043}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"圣湘生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"19842人(较上一季度减少2.27%)","perCapita":"29200股","listingDate":"2020-08-28","address":"湖南省长沙市岳麓区高新技术产业开发区麓松路680号","registeredCapital":"57938万元","survey":"　　圣湘生物科技股份有限公司的主营业务为以自主创新基因技术为核心，集诊断试剂和仪器的研发、生产、销售，以及第三方医学检验服务于一体的体外诊断整体解决方案，其主要产品为病毒性肝炎系列产品、生殖道感染与遗传系列产品、儿科感染系列产品、呼吸道感染系列产品、核酸血液筛查系列产品、科研、公共卫生、动物疫病系列产品、核酸提取系列产品、生化系列产品、全自动核酸检测反应体系构建系列产品、POCT移动分子诊断系统系列产品、荧光PCR检测分析软件、第三方医学检验服务、科研服务。","listedPrice":50.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣湘生物,688289,圣湘生物股票,圣湘生物股票老虎,圣湘生物股票老虎国际,圣湘生物行情,圣湘生物股票行情,圣湘生物股价,圣湘生物股市,圣湘生物股票价格,圣湘生物股票交易,圣湘生物股票购买,圣湘生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}